Consensus conferences as drug promotion.
作者信息
Kingswell R S
出版信息
Lancet. 1993 Feb 6;341(8841):368.
PMID:8094128
Abstract
摘要
相似文献
1
Consensus conferences as drug promotion.作为药品推广手段的共识会议。
Lancet. 1993 Feb 6;341(8841):368.
2
Consensus conferences as drug promotion.作为药品推广手段的共识会议
Lancet. 1993 Feb 6;341(8841):368-9.
3
Consensus conferences as drug promotion.作为药品推广手段的共识会议。
Lancet. 1993 Jan 9;341(8837):100-2. doi: 10.1016/0140-6736(93)92569-f.
4
Consensus on high-density lipoprotein.
Br J Hosp Med. 1991 Sep;46(3):185.
5
Consensus reports from the convinced: manipulating the information transfer process for drug promotion.来自坚信者的共识报告：操纵药品推广的信息传递过程。
JAMA. 1991 Jan 2;265(1):30. doi: 10.1001/jama.1991.03460010030022.
6
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.在退伍军人事务部高密度脂蛋白干预试验中，低密度脂蛋白和高密度脂蛋白颗粒亚类可预测冠状动脉事件，并且吉非贝齐治疗可使其发生有利变化。
Circulation. 2006 Mar 28;113(12):1556-63. doi: 10.1161/CIRCULATIONAHA.105.565135. Epub 2006 Mar 13.
7
Consensus conferences as drug promotion.作为药品推广手段的共识会议。
Lancet. 1993 Feb 20;341(8843):499. doi: 10.1016/0140-6736(93)90255-f.
8
Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.吉非贝齐对高甘油三酯血症患者极低密度脂蛋白和高密度脂蛋白组成及氧化特性的影响。
J Lab Clin Med. 2001 Jun;137(6):414-21. doi: 10.1067/mlc.2001.114991.
9
Summary of the NIH Consensus. Triglycerides, high density lipoproteins, and coronary heart disease.
Pa Nurse. 1993 Jan;48(1):7-8.
10
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
Arch Intern Med. 1994 Jan 10;154(1):73-82.
Zotero 插件